Terns Pharmaceuticals Inc...

2.48
-0.08 (-3.13%)
At close: Apr 02, 2025, 3:59 PM
2.44
-1.44%
After-hours: Apr 02, 2025, 07:55 PM EDT

Terns Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Revenue n/a n/a n/a 1M n/a n/a n/a
Cost of Revenue n/a 881K 1.03M 512K 394K 195K 65K
Gross Profit n/a -881K -1.03M 488K -394K -195K -65K
Operating Income -101.87M -102.56M -62.03M -49.86M -37.02M -70.2M -18.45M
Interest Income 13.29M 12.9M 2.11M 170K 55K 1.2M 332K
Pretax Income -88.59M -89.97M -59.99M -49.65M -39.76M -68.84M -18.09M
Net Income -88.85M -90.21M -60.34M -50.16M -40.57M -68.82M -17.71M
Selling & General & Admin 31.76M 39.06M 22.41M 19.55M 9M 8.66M 3.9M
Research & Development 70.11M 63.5M 39.62M 31.31M 28.03M 61.53M 14.55M
Other Expenses n/a n/a -68K 40K -2.79M 154K 38K
Operating Expenses 101.87M 102.56M 62.03M 50.86M 37.02M 70.2M 18.45M
Interest Expense n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 102.56M 62.03M 50.86M 37.02M 70.2M 18.45M
Income Tax -260K 239K 358K 508K 813K -20K -67K
Shares Outstanding (Basic) 79.51M 71.26M 36.03M 25.27M 25.13M 25.1M 23.97M
Shares Outstanding (Diluted) 79.51M 71.26M 36.03M 25.27M 25.13M 25.1M 23.97M
EPS (Basic) -1.12 -1.27 -1.67 -1.98 -1.61 -2.74 -0.74
EPS (Diluted) -1.12 -1.27 -1.67 -1.98 -1.61 -2.74 -0.74
EBITDA -101.87M -102.27M -58.95M -49.35M -36.63M -35M -18.39M
EBIT n/a -102.56M -62.03M -49.86M -37.02M -68.84M -18.45M
Depreciation & Amortization n/a 292K 1.03M 512K 394K 195K 65K